
India faces a growing obesity challenge influenced by hormonal, genetic, and lifestyle factors. New medications like semaglutide and tirzepatide, which mimic appetite-regulating hormones, have shown effectiveness in weight and metabolic management. Experts emphasize these drugs are not quick fixes but part of a holistic approach including lifestyle, hormonal, and psychological interventions. The upcoming expiry of semaglutide's patent in India may increase access to affordable generics, potentially expanding treatment options amid rising obesity rates.
Select a news story to see related coverage from other media outlets.